AZD5153 in Participants With Relapsed or Refractory Solid Tumors, including Lymphomas

Trial Identifier: D6520C00001
Sponsor:AstraZeneca
NCTID:NCT03205176
Start Date:June 2017
Primary Completion Date: March 2021
Study Completion Date: April 2021
Condition: Breast Cancer; Cancer - Other; Lymphoma; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

LanguageDescription
English Version

Trial Locations

CountryLocation
US, TN Nashville, TN, US, 37203
US, FL Sarasota, FL, US, 34232
US, OK Oklahoma City, OK, US, 73104
CA, CA Toronto, CA, CA, M5G 2M9